BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas C, Ammar A, Farrell J, Elsaleh H. Radiation Modifiers: Treatment Overview and Future Investigations. Hematology/Oncology Clinics of North America 2006;20:119-39. [DOI: 10.1016/j.hoc.2006.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol) 2007;19:397-417. [PMID: 17478086 DOI: 10.1016/j.clon.2007.03.010] [Cited by in Crossref: 285] [Cited by in F6Publishing: 251] [Article Influence: 19.0] [Reference Citation Analysis]
2 Braunstein S, Nakamura JL. Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol 2013;3:73. [PMID: 23565507 DOI: 10.3389/fonc.2013.00073] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
3 Suh DC, Powers CA, Barone JA, Shin H, Kwon J, Goodin S. Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: A microcosting study. Res Social Adm Pharm 2010;6:246-56. [PMID: 20813337 DOI: 10.1016/j.sapharm.2009.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]